I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
What Is Uveitis? Understanding Eye Inflammation and Your Vision
Understanding the Uvea and How Uveitis Develops
The uvea is the middle layer of the eye wall, rich in blood vessels that nourish the eye's internal structures. Learning what the uvea does and how inflammation disrupts it helps explain why uveitis can affect vision in so many different ways.
The uvea sits between the outer white layer of the eye, called the sclera, and the inner light-sensitive layer called the retina. It has three distinct parts. The iris is the colored ring visible around the pupil. The ciliary body is a ring of muscle and tissue just behind the iris that adjusts the shape of the lens so the eye can focus. The choroid is a thin layer of blood vessels lining the inside of the eye beneath the retina.
Because the uvea supplies oxygen and nutrients to so many surrounding structures, inflammation in any part of it can quickly affect vision. Left untreated, that inflammation can also spread to the retina and the optic nerve, the cable that carries visual information to the brain.
Under normal conditions, the eye is shielded by a blood-ocular barrier that keeps immune cells from entering its interior spaces. Uveitis begins when this barrier breaks down and white blood cells invade the eye, triggering swelling and tissue damage.
In autoimmune forms of uveitis, a type of immune cell called a T cell mistakenly targets proteins inside the eye as if they were harmful. Research suggests that gut bacteria may play a role in activating this abnormal immune response. Once triggered, these T cells travel through the bloodstream, enter the eye, and drive ongoing inflammation.
Retina specialists classify uveitis by the location of inflammation, because the type determines how treatment is approached.
- Anterior uveitis affects the front of the eye, primarily the iris, and is the most common form.
- Intermediate uveitis involves the ciliary body and the vitreous, the clear gel that fills the middle of the eye.
- Posterior uveitis affects the choroid and retina at the back of the eye, making it the type most directly managed by retina specialists.
- Panuveitis means inflammation is present throughout all three sections of the uvea at the same time.
Uveitis does not behave the same way in every patient. An acute episode comes on quickly and typically lasts a few weeks. Recurrent uveitis describes episodes that resolve and then return after quiet periods. Chronic uveitis persists for three months or longer and often requires ongoing treatment to keep inflammation suppressed and vision protected.
Who Is at Risk for Uveitis?
Uveitis can affect people of any age, but certain health conditions, genetic factors, and lifestyle choices raise the risk considerably. Knowing your risk factors helps ensure you are appropriately monitored and referred for care when needed.
Uveitis affects far more people than is generally recognized. In the United States, the cumulative prevalence has been estimated at approximately 260 cases per 100,000 people. The condition most commonly develops in adults between 20 and 60 years old, though it can occur at any age, including in children.
People living with certain autoimmune diseases have a significantly higher risk of developing uveitis. Associated conditions include ankylosing spondylitis (an inflammatory arthritis that primarily affects the spine), inflammatory bowel disease, rheumatoid arthritis, lupus, sarcoidosis, and Behcet disease.
A genetic marker called HLA-B27 is strongly linked to acute anterior uveitis. Research indicates that between 50 and 80 percent of patients who develop this specific form of uveitis test positive for this marker.
Several infections can cause uveitis by triggering an immune response inside the eye. Known infectious causes include herpes simplex virus, herpes zoster (the virus responsible for shingles), syphilis, toxoplasmosis (a parasitic infection), tuberculosis, and Lyme disease. When an infection is identified as the underlying trigger, treating that infection directly is an essential part of managing the eye inflammation.
Smoking cigarettes is an established risk factor for uveitis and is associated with worse outcomes. Certain medications may also trigger the condition, including bisphosphonates (used to treat osteoporosis), checkpoint inhibitors (immunotherapy drugs used in cancer treatment), and some live vaccines.
Women tend to have a higher overall prevalence of uveitis in adult populations. Environmental factors and the composition of gut bacteria may also influence who develops the condition, though research in these areas is continuing.
Recognizing the Signs and Symptoms
The symptoms of uveitis vary depending on which part of the eye is affected and whether the inflammation came on suddenly or gradually. Some symptoms are hard to miss, while others develop quietly until vision is noticeably affected.
Many people with uveitis notice one or more of the following signs. These symptoms may develop over hours or across several days.
- Eye pain or a deep aching sensation
- Redness in the white of the eye
- Sensitivity to light, known as photophobia
- Blurred or reduced vision
- Floaters, which are dark specks or strands that drift across the field of vision
Even mild discomfort that persists warrants a prompt eye evaluation. Early detection leads to earlier treatment and a better chance of preserving vision.
Some symptoms signal a serious, immediate threat to vision. Do not wait for a routine appointment if you experience sudden eye pain with redness, a rapid increase in floaters, flashes of light, a dark shadow or curtain moving across your visual field, or sudden unexplained vision loss. These signs may indicate that uveitis is actively damaging structures inside the eye. Please seek care from a retina specialist or go to the nearest emergency room right away.
Anterior uveitis tends to produce the most noticeable outward signs, including significant pain, redness, and light sensitivity. Intermediate and posterior uveitis may cause fewer external symptoms but can result in substantial floaters and blurred vision. Posterior uveitis is especially concerning because the inflammation directly involves the retina, the structure responsible for sharp central and peripheral vision. Panuveitis may involve all of these symptoms simultaneously.
How Uveitis Is Diagnosed
Accurate diagnosis is the foundation of effective treatment. Our retina specialists use a combination of clinical examination, advanced imaging, and laboratory testing to identify the type of uveitis and its underlying cause.
A retina specialist will begin with a thorough examination using a slit lamp, a specialized microscope that provides a magnified, illuminated view of both the front and back of the eye. During this exam, the specialist looks for inflammatory cells floating in the fluid inside the eye, protein deposits on the back of the cornea (the clear dome at the front of the eye), and signs of swelling or damage in the retina.
Several advanced imaging technologies help evaluate the full extent of inflammation and identify any complications before they worsen.
- Optical coherence tomography (OCT) creates detailed cross-sectional images of the retina and can detect macular edema, which is fluid-related swelling in the central retina that reduces sharp vision.
- Fluorescein angiography involves injecting a dye into a vein in the arm and photographing the retinal blood vessels to reveal leakage, structural damage, or areas of poor circulation.
- ICG (indocyanine green) angiography provides additional detail about the deeper choroidal blood vessels and is especially useful in evaluating posterior uveitis.
- Ophthalmic ultrasound may be used when inflammation is too severe to allow a clear view of the back of the eye through traditional means.
Because uveitis is frequently linked to systemic diseases or infections, a retina specialist may order laboratory blood tests as part of the diagnostic workup. These can screen for HLA-B27, markers associated with sarcoidosis, syphilis, tuberculosis, Lyme disease, and other conditions.
Identifying an underlying cause shapes the entire treatment plan. In many cases, even after a thorough evaluation, no specific cause is found. This is called idiopathic uveitis and accounts for a significant portion of diagnosed cases.
Retina specialists use standardized classification criteria developed by the Standardization of Uveitis Nomenclature (SUN) Working Group to identify the precise form of uveitis a patient has. This system covers 25 recognized subtypes and helps ensure that treatment is matched to the specific diagnosis. Machine learning tools are increasingly being applied to these criteria to support more consistent diagnoses and to accelerate research into new treatments.
Treatment Options for Uveitis
Treatment depends on the type of uveitis, its severity, the underlying cause, and whether the condition is acute or chronic. Our retina specialists develop an individualized plan for each patient and adjust the approach over time as the disease responds.
Corticosteroids are anti-inflammatory medications and the most widely used first-line treatment for uveitis. They work by quickly suppressing the immune response inside the eye. Depending on the location and severity of inflammation, corticosteroids can be delivered in several ways.
- Topical eye drops, which are most effective for anterior uveitis
- Periocular injections, meaning injections placed around the outside of the eye, used for intermediate or posterior inflammation
- Intravitreal injections, which deliver medication directly into the vitreous cavity inside the eye, for more severe or vision-threatening cases
- Oral corticosteroids for widespread or bilateral inflammation
Clinical evidence from the POINT Trial demonstrated that intravitreal steroid delivery is more effective than periocular delivery for treating uveitic macular edema, the fluid buildup in the central retina that uveitis can cause.
For patients with intermediate, posterior, or panuveitis who need continuous anti-inflammatory protection over many months, a steroid-releasing implant placed inside the eye may be recommended. These implants deliver medication directly at the site of inflammation, reducing the need for frequent office injections or ongoing oral medications.
A biodegradable dexamethasone implant releases medication gradually over several months. A longer-lasting fluocinolone acetonide implant can provide treatment for up to three years. The appropriate implant depends on each patient's specific circumstances and prior treatment history.
Long-term corticosteroid use carries meaningful risks, including accelerated cataract formation and elevated pressure inside the eye, which can progress to glaucoma. When uveitis is chronic or steroids are causing side effects, our specialists may recommend steroid-sparing immunosuppressive medications that work by modifying how the immune system responds rather than simply dampening inflammation.
Methotrexate is the most widely used option in this category. Evidence from the FAST Trial showed that methotrexate is at least as effective as, and in some cases more effective than, mycophenolate mofetil for treating posterior uveitis and panuveitis. Mycophenolate mofetil remains a valuable alternative for patients who cannot tolerate methotrexate.
Biologic agents are a class of medications that target specific proteins in the immune system. For patients with severe, treatment-resistant, or frequently recurring uveitis, biologic therapy may be an important option.
Adalimumab is currently the only FDA-approved systemic biologic medication for adult noninfectious intermediate, posterior, and panuveitis. Multiple biosimilar versions, which are lower-cost medications with the same active ingredient, have become available in recent years, helping improve access to this treatment. Research into additional biologic approaches, including medications targeting the IL-6 pathway and other immunomodulatory agents, is actively ongoing.
When uveitis is caused by an identifiable infection, treating that infection is a critical first step. Depending on the causative organism, treatment may include antiviral, antibiotic, antifungal, or antiparasitic medications. Using immunosuppressive therapy without first addressing an active infection could significantly worsen the condition, so the sequence and combination of treatments must be carefully coordinated by your retina specialist.
What to Expect During and After Treatment
Starting treatment for uveitis often involves an intensive early phase followed by gradual adjustments as inflammation responds. Understanding what lies ahead can make the process feel more manageable.
In the early stages, office visits may be more frequent than you might expect. If you are using corticosteroid eye drops, you may apply them many times a day at first, then gradually reduce the frequency as inflammation comes under control. After an injection or implant procedure, we schedule close follow-up visits to evaluate your response and watch for any side effects.
Patients on immunosuppressive medications or biologic agents typically need periodic blood tests to monitor how their body is tolerating the treatment. It can take several weeks to see the full benefit of these medications, so consistency with your treatment plan matters greatly.
Uveitis that is not treated promptly, or that proves difficult to control, can lead to complications affecting vision. These include:
- Cystoid macular edema (CME), a form of fluid-related swelling in the center of the retina that reduces sharp central vision
- Cataracts, a clouding of the eye's natural lens
- Glaucoma, a condition in which increased eye pressure damages the optic nerve
- Retinal detachment, where the retina separates from the back wall of the eye
- Permanent vision loss in severe or inadequately treated cases
Many of these complications are preventable with early and consistent care. When a complication does develop, our specialists have the surgical expertise to address it directly.
The prognosis for uveitis depends on its type, the underlying cause, and how early treatment begins. Many people with acute anterior uveitis respond well to short-term treatment and achieve a good visual outcome. Chronic and posterior forms generally require more complex, longer-term management.
With regular monitoring and a well-matched treatment plan, many patients are able to maintain useful, functional vision for years. Seeking care promptly when symptoms appear remains the single most important factor in a favorable long-term outcome.
Living Well With Uveitis
A diagnosis of uveitis, particularly a chronic or recurrent form, can affect your daily life in ways that extend well beyond your eyes. Managing the condition well involves consistent follow-up, attention to your overall health, and honest communication with your care team.
Even when your eyes feel comfortable and your vision seems stable, inflammation can return without obvious warning. Regular follow-up appointments allow our specialists to detect early signs of a flare through examination and imaging before symptoms become noticeable. Keeping every scheduled appointment is one of the most effective steps you can take to protect your vision over time.
Because uveitis is so often connected to systemic autoimmune or inflammatory diseases, managing your overall health plays an important role in protecting your eye health as well. Coordinating care with your primary care physician, rheumatologist, or other specialists helps keep underlying conditions under control, which in turn reduces the likelihood of uveitis flares.
If you smoke, quitting is strongly recommended. Smoking is a recognized risk factor for uveitis and is associated with poorer outcomes in patients with inflammatory eye disease.
Chronic or recurrent uveitis can be emotionally difficult. Vision changes may affect your ability to drive, read, work, or participate in the activities you value most. Speaking openly with your retina specialist about how the condition is affecting your daily life helps us factor quality of life into your care plan.
Patient education resources from organizations such as the American Academy of Ophthalmology and the National Eye Institute can help you better understand your condition and connect with others who share similar experiences.
When to See a Retina Specialist
Knowing when to seek specialized retina care, and how urgently, can make a meaningful difference in your visual outcome.
Certain symptoms should never be ignored or delayed. Seek care right away from a retina specialist or go to the emergency room if you experience sudden eye pain with redness, a rapid increase in floaters or the sudden appearance of new ones, flashes of light, a dark curtain or shadow spreading across your visual field, or abrupt unexplained vision loss. These symptoms may indicate active, vision-threatening inflammation inside the eye. Prompt evaluation can prevent permanent damage.
If you have been diagnosed with an autoimmune condition such as ankylosing spondylitis, sarcoidosis, inflammatory bowel disease, or Behcet disease, ask your doctor about regular uveitis screening. An optometrist or primary care physician can perform an initial evaluation, but intermediate, posterior, and panuveitis are best managed by a retina specialist with dedicated training in ocular inflammatory disease.
Early referral leads to earlier treatment and, in most cases, a significantly better visual outcome. If you have recently been diagnosed with uveitis by another provider, you do not need to wait for a formal referral to schedule an evaluation with our team.
Frequently Asked Questions
Here are answers to questions our team hears most often from patients navigating a uveitis diagnosis.
Yes, uveitis can cause permanent vision loss when it goes untreated or when inflammation is severe and difficult to control. According to the American Academy of Ophthalmology, uveitis is estimated to account for roughly 10 percent of all blindness cases in the United States. That figure reflects cases where disease was severe or inadequately managed over time. With early diagnosis and consistent treatment, many patients are able to maintain functional vision for years. The most protective step you can take is seeking evaluation as soon as symptoms appear and following through with your full course of recommended care.
Uveitis itself is not contagious. You cannot catch it from another person or transmit it through contact. In certain cases, the underlying trigger may be an infection such as herpes or toxoplasmosis that could be transmitted separately between individuals, but the eye inflammation itself is your own immune system's response and does not spread from person to person.
Duration varies considerably depending on the type and severity. Acute anterior uveitis often resolves within a few weeks with appropriate treatment. Chronic forms, particularly posterior uveitis and panuveitis, can persist for months and may require continuous medication to keep inflammation suppressed. Because every patient responds differently, the pace of recovery and the length of any given flare are things your retina specialist will monitor closely and adjust your treatment plan around over time.
Not necessarily. Some patients experience a single episode that resolves with short-term treatment and never recurs. Others have recurrent or chronic forms that benefit from long-term immunosuppressive therapy to prevent flares and protect vision. The goal is always to achieve the best possible disease control at the lowest effective level of treatment. Your retina specialist will reassess and adjust your medication plan on an ongoing basis based on how your eyes are responding.
Yes. Data from the IRIS Registry estimate the annual prevalence of pediatric noninfectious uveitis in the United States at approximately 12 cases per 100,000 patients. In children, uveitis is commonly associated with juvenile idiopathic arthritis and may develop without the obvious symptoms of pain or redness that adults typically notice, making it easy to miss without routine screening. If your child has a known autoimmune condition, regular dilated eye examinations are important for detecting uveitis early, before it has the chance to affect developing vision.
Schedule Your Evaluation With Our Team
If you are experiencing symptoms of uveitis, have already been diagnosed elsewhere, or have a systemic condition that puts you at higher risk, New England Retina Associates is here to help. Our fellowship-trained retina specialists provide advanced, individualized care at four offices across Connecticut, and we welcome both self-referred patients and those referred by other eye care providers. We bring deep expertise in all forms of ocular inflammatory disease, from straightforward anterior uveitis to the most complex posterior and panuveitis cases. Contact us today to schedule an evaluation and take an important step toward protecting your vision.
30 Years of Care & Commitment
